New gene test for prostate cancer at hand

	Tweet

Men with susceptibility for prostate cancer will soon be identifiable through a simple DNA test. So hope scientists at the Swedish medical university Karolinska Institutet, who have shown that men carrying a combination of known risk genes run a four to five times higher risk of developing prostate cancer.

At present, men with suspected prostate cancer are identified mainly using what are known as PSA tests. However, the test has a relatively low sensitivity and better methods are needed.

“In the near future, it will be possible to combine PSA tests with simple genetic tests,” says Professor Henrik Grönberg at Karolinska Institutet. “This means that fewer men will have to undergo unnecessary biopsies and that more prostate cancer diagnoses can be made.”

It has long been known that prostate cancer is partly caused by inherited factors, which makes some men more likely to develop the disease than others. Five relatively common gene variants that affect this risk have so far been identified. However, each of these variants affects the risk only marginally, and knowledge of them has been of no real benefit to individual patients.

Now, however, a research group at Karolinska Institutet and their American colleagues have analysed for the first time the cumulative effect of these gene variants. The results, which are published in the prestigious scientific periodical The New England Journal of Medicine, shows that men who carry four or more risk variants run a four to five times greater risk of developing prostate cancer. This risk is increased even more if they also had close relatives with the disease.

According to the researchers, this is the first time that anyone has been able to demonstrate how a combination of genes affect the risk of developing the disease. Scientists the world over are currently searching for gene combinations behind common diseases like cancer, diabetes and asthma.

“For the first time, this type of study has made it possible to develop a clinically viable gene test,” says Professor Grönberg.

The study was based on genetic analyses of approximately 4,800 Swedish men, of whom 3,000 had prostate cancer and 1,800 had no prostate cancer diagnosis.
Publication:

S. Lilly Zheng, Jielin Sun, Fredrik Wiklund, Shelly Smith, Pär Stattin, Ge Li, Hans-Olov Adami, Fang-Chi Hsu, Yi Zhu, Katarina Bälter, A. Karim Kader, Aubrey R. Turner, Wennuan Liu, Eugene R.Bleecker, Deborah A. Meyers, David Duggan, John D. Carpten, Bao-Li Chang, William B. Isaacs, Jianfeng Xu, and Henrik Grönberg
Cumulative association of five genetic variants with prostate cancer

New England Journal of Medicine, online 16 januari 2008. 

RELATED STORIES:
Older men get less effective prostate cancer care   Being active may ward off prostate cancer death   Vaccine Injection Targeted in Building a Better ‘Bull’s-Eye’ to Fight Prostate Cancer   University of Oklahoma Scientists Discover Way to Stop Pancreatic Cancer in Early Stages   Prostate Cancer Risk Among Users of Finasteride and Alpha-Blockers   Delay OK before radiation for prostate cancer   Exercise Reduces Death Rate in Prostate Cancer Patients   Men who stay trim less apt to get prostate cancer   Genetic map of prostate cancer cracked   Dutasteride useful for enlarged prostate   Racial disparity seen in prostate cancer treatment   Curry Spice Component May Help Slow Prostate Tumor Growth   On Sex After Prostate Surgery, Confusing Data   Acquisition of Robotic Technology Leads to Increased Rates of Prostate Cancer Surgery   Guide aims to help men understand prostate cancer   Castrate resistant prostate cancer: New therapeutic approaches   Study finds prostate screening cuts cancer deaths   Proton Therapy Effective Prostate Cancer Treatment   Study Looks at Celebrex and Lipitor to Treat Prostate Cancer   Testicular cancer patients can have children   Obese men less likely to get biopsy after PSA screening   Prostate cancer clinical stage does not predict recurrence

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]